This general oncogenic role of ERO1α aligns closely with our review’s findings in breast cancer, where consistent evidence shows markedly higher ERO1α expression in breast cancer cells compared to normal mammary tissue [24,25]. The gene discussed is ERO1A; the disease is breast cancer.